ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Manager, People Operations at Revolution Medicines - ApplyBlast

Manager, People Operations

Revolution Medicines

17 days ago

3.5 on Glassdoor

Redwood City, California, United States

Hybrid

Full Time

Manager

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Manager, People Operations leads the day-to-day delivery of core People Operations services within the U.S. and Canada, including employee lifecycle operations, data administration, and HR operational support. This hands-on role ensures accurate and consistent execution of payroll inputs, employee records, and audits while managing escalations and driving process improvements. The position partners closely with HR, Finance, Payroll, and IT to deliver scalable solutions and support the company's rapid growth.

Responsibilities

Lead day-to-day People Operations service delivery and team management
Oversee accurate employee transactions and data changes in Workday
Identify and implement process improvements using automation and AI

Skills

Qualifications

Bachelor's degree in human resources, business administration, a related field, or equivalent practical experience

About Revolution Medicines

revmed.com

Headquarters

Redwood City, California, United States

Company Size

201-500 employees

Founded

2014

View Profile

Revolution Medicines (RevMed) is a biopharmaceutical company dedicated to discovering, developing, and delivering novel targeted medicines for patients with cancer. Their mission focuses specifically on "revolutionizing treatment for patients with RAS‑addicted cancers" through precision-targeted therapies. The company emphasizes a science-driven, end-to-end approach from discovery to delivery. RevMed brands its team as "Revolutionaries" committed to transforming outcomes for people with RAS‑driven tumors.